for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Pfizer Inc.

PFE

Latest Trade

40.02USD

Change

-0.08(-0.20%)

Volume

18,041,053

Today's Range

39.92

 - 

40.32

52 Week Range

31.61

 - 

43.08

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
40.10
Open
40.24
Volume
18,041,053
3M AVG Volume
639.75
Today's High
40.32
Today's Low
39.92
52 Week High
43.08
52 Week Low
31.61
Shares Out (MIL)
5,597.69
Market Cap (MIL)
224,019.70
Forward P/E
10.51
Dividend (Yield %)
3.90

Next Event

Q2 2021 Pfizer Inc Earnings Release

Latest Developments

More

U.S. CDC Says Administered 270.8 Mln Doses Of COVID-19 Vaccine As Of May 15

U.S. CDC Says Delivered 341.9 Million Doses Of Covid-19 Vaccine As Of May 14

U.S. CDC Says Delivered 339,165,445 Doses Of Covid-19 Vaccine As Of May 13 Versus 337,089,765 Doses Delivered As Of May 12

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Pfizer Inc.

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

Industry

Biotechnology & Drugs

Contact Info

235 E 42ND ST

NEW YORK, NY

10017-5703

United States

+1.212.5732323

https://www.pfizer.com/

Executive Leadership

Albert Bourla

Chairman of the Board, Chief Executive Officer

John D. Young

Chief Business Officer, Group President

Frank A. D'amelio

Chief Financial Officer, Executive Vice President - Global Supply

Angela Hwang

Group President, Pfizer Biopharmaceuticals Group

Lidia Fonseca

Executive Vice President, Chief Technology Officer and Digital Officer

Key Stats

2.64 mean rating - 22 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

53.6K

2019

51.8K

2020

41.9K

2021(E)

74.2K
EPS (USD)

2018

3.000

2019

2.950

2020

2.220

2021(E)

3.808
Price To Earnings (TTM)
23.99
Price To Sales (TTM)
4.83
Price To Book (MRQ)
3.26
Price To Cash Flow (TTM)
15.75
Total Debt To Equity (MRQ)
57.85
LT Debt To Equity (MRQ)
51.51
Return on Investment (TTM)
7.15
Return on Equity (TTM)
5.80

Latest News

Latest News

Italian study shows COVID-19 infections, deaths plummeting after jabs

COVID-19 infections in adults of all ages fell by 80% five weeks after a first dose of Pfizer, Moderna or AstraZeneca vaccine, according to Italian research published on Saturday.

Delayed 2nd Pfizer/BioNTech shot boosts antibodies in elderly; COVID-19 obesity risk higher for men

The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

Pfizer says 'good reason' to believe in success of anti-viral drug

The chief executive of Pfizer Inc said on Friday he had "very good reason" to believe in the success of an oral COVID-19 antiviral therapy by the drugmaker now in an early-stage U.S. trial.

UPDATE 1-Vietnam seeks 31 mln doses of Pfizer-BioNTech vaccine in 2021

Vietnam is seeking 31 million doses of the COVID-19 vaccine jointly developed by Pfizer and BioNTech in 2021, its health ministry said on Friday, as the country seeks to secure its vaccines amid competition and supply uncertainty.

Delayed second Pfizer COVID-19 shot produces more antibodies - study

Pfizer's COVID-19 vaccine generates antibody responses three-and-a-half times larger in older people when a second dose is delayed to 12 weeks after the first, a British study said.

Pfizer got no response to offers to supply vaccine to Brazil last year, exec says

Pfizer Inc repeatedly offered to sell its COVID-19 vaccine to Brazil's Health Ministry between August and November last year, but got no answer from the government, Pfizer's chief executive for Latin America told lawmakers on Thursday.

UPDATE 1-Pfizer got no response to offers to supply vaccine to Brazil last year, exec says

Pfizer Inc repeatedly offered to sell its COVID-19 vaccine to Brazil's Health Ministry between August and November last year, but got no answer from the government, Pfizer's chief executive for Latin America told lawmakers on Thursday.

Quebec, New Brunswick stop offering first doses of AstraZeneca vaccine

The Canadian provinces of Quebec and New Brunswick will no longer offer first doses of the AstraZeneca COVID-19 vaccine, but will offer second doses using current supplies and future deliveries, the provinces said on Thursday.

CDC panel clears way to COVID-19 vaccines for U.S. adolescents

U.S. states are set to begin using the vaccine from Pfizer Inc and BioNTech SE to inoculate young adolescents against COVID-19 after advisers to the U.S. Centers for Disease Control and Prevention (CDC) backed the plan in a unanimous vote on Wednesday.

U.S. schools unlikely to mandate COVID-19 vaccines anytime soon

Pfizer and BioNTech's COVID-19 vaccine was authorized for use in children as young as 12 by the U.S. Food and Drug Administration this week - but do not expect schools to require shots for students anytime soon given public hesitation and political hurdles.

UAE allows Pfizer COVID-19 dose for emergency use in 12-15 year olds

The United Arab Emirates has approved the Pfizer and BioNTech COVID-19 vaccine for emergency use in children aged 12-15, the government said on Thursday, having already permitted its use for 16 years and above.

No shot: U.S. schools unlikely to mandate COVID-19 vaccines anytime soon

Pfizer's COVID-19 vaccine won approval for use in children as young as 12 from the U.S. Food and Drug Administration this week - but do not expect schools to require shots for students anytime soon amid public hesitation and political hurdles.

Spain is on track for herd immunity, PM says

More than two thirds of Spain's 47 million people will have been vaccinated against COVID-19 by mid-August, Prime Minister Pedro Sanchez said on Thursday.

Biden urges parents to get kids vaccinated after CDC panel OKs Pfizer vaccine

U.S. President Joe Biden on Wednesday urged parents to get their children vaccinated after a government advisory panel authorized the Pfizer's COVID-19 vaccine for children aged 12 to 15.

mRNA vaccines appear effective vs India variant; people with HIV at higher risk for severe COVID-19

The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

Fact Check-A two-year-old did not die during Pfizer’s pediatric COVID-19 vaccine trial

A two-year-old did not die during Pfizer-BioNTech’s ongoing COVID-19 vaccine trial in kids under 12, contrary to claims on social media. An unverified entry saying so in the United States’ federal vaccine safety surveillance database has since been removed for being fabricated...

Pfizer to seek COVID-19 vaccine approval in Mexico for children aged 12-15

U.S. pharmaceutical maker Pfizer Inc will seek authorization from Mexico's health regulator for use of its COVID-19 vaccine in children aged 12-15, Mexican Foreign Minister Marcelo Ebrard said on Wednesday.

Australia taps Moderna for 25 million COVID-19 shots in vaccination ramp up

Australia on Wednesday tapped Moderna Inc for 25 million COVID-19 vaccine doses, as it tries to speed up vaccination in people under 50 after deciding against AstraZeneca, whose jab has been linked to rare blood clots.

Brazil ex-health minister saw no need for Pfizer vaccine, say sources

Former Brazilian Health Minister Eduardo Pazuello failed to take up Pfizer Inc on its offer of COVID-19 vaccines last year because he believed Brazil should rely on British and Chinese shots made in the country, two sources told Reuters.

WHO reviewing Vietnam proposal to produce mRNA COVID-19 vaccines

The World Health Organization (WHO) said on Wednesday it was reviewing a proposal by an unidentified vaccine manufacturer in Vietnam to become an mRNA-based COVID-19 vaccine technology hub in the Southeast Asian country.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up